Maria Maccecchini
-
Malvern-Based Annovis Bio Reports Positive Clinical Trial Results for Parkinson’s Disease Drug
Malvern-based Annovis Bio recently reported positive clinical trial results for buntanetap, the biopharmaceutical company’s lead new drug candidate in Parkinson’s disease patients, writes John George…
-
Malvern-Based Annovis Bio to Focus Future Development of Its Experimental Drug on Early Alzheimer’s Patients
Malvern-based Annovis Bio plans to focus on patients who have the early form of Alzheimer’s disease in the future development of its experimental treatment for…
-
Berwyn-Based Annovis Bio Postpones Release of Data for Its Experimental Parkinson’s Treatment
Berwyn-based Annovis Bio is delaying the release of the late-stage study results of its experimental Parkinson’s disease treatment, writes John George for the Philadelphia Business…
-
Positive News About Berwyn-based Annovis Bio’s Experimental Alzheimer’s Therapy Sends Stock Soaring
Positive news about Berwyn-based Annovis Bio’s experimental Alzheimer’s disease therapy bumped the company’s stock up by 16 percent Monday during mid-afternoon trading, writes John George…
-
Berwyn Biotech Company Raises Millions to Advance Parkinson’s, Alzheimer’s Treatment
Annovis Bio, a Berwyn-based biotech company, has managed to raise $8.7 million to advance its experimental treatment for Parkinson’s and Alzheimer’s diseases, writes John George…
-
Berwyn-Based Pharmaceutical Company Going Public
Annovis Bio, the pharmaceutical company in Berwyn working on potential treatments for neurological disorders such as Alzheimer’s and Parkinson’s diseases, has filed for an IPO,…
-
Private Stock Sale Nets Half a Mil for Local Biopharma Company Battling Alzheimer’s, Parkinson’s
Berwyn-based QR Pharma, the biopharmaceutical company developing treatments for a number of neurological disorders, including Alzheimer’s and Parkinson’s diseases, has raised $530,000 in a private…
-
Chester County Briefly: October 31
Pennsylvania American Water and Coatesville Pennsylvania American Water welcomed stakeholders from the Coatesville area last Thursday to celebrate the 25th anniversary of the company’s Help…
-
QR Pharma, Rockefeller University Research Drug For Huntington’s Disease
QR Pharma, Inc. of Berwyn is collaborating with The Rockefeller University to develop a treatment for Huntington’s disease. The collaboration will focus on preclinical research…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
